Os Therapies Incorporated Stock Performance
| OSTX Stock | 3.97 0.06 1.53% |
On a scale of 0 to 100, OS Therapies holds a performance score of 6. The company owns a Beta (Systematic Risk) of 1.06, which implies a somewhat significant risk relative to the market. OS Therapies returns are very sensitive to returns on the market. As the market goes up or down, OS Therapies is expected to follow. Please check OS Therapies' treynor ratio, expected short fall, and the relationship between the jensen alpha and potential upside , to make a quick decision on whether OS Therapies' current price history will revert.
Risk-Adjusted Performance
6 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in OS Therapies Incorporated are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting basic indicators, OS Therapies showed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 1.53 | Five Day Return 22.15 | Year To Date Return 58.17 | Ten Year Return 58.17 | All Time Return 58.17 |
1 | Insider Trading | 10/28/2024 |
2 | OS Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update - Yahoo Finance | 11/15/2024 |
| Begin Period Cash Flow | 171.5 K |
OSTX |
OS Therapies Relative Risk vs. Return Landscape
If you would invest 321.00 in OS Therapies Incorporated on September 22, 2024 and sell it today you would earn a total of 76.00 from holding OS Therapies Incorporated or generate 23.68% return on investment over 90 days. OS Therapies Incorporated is currently generating 0.8419% in daily expected returns and assumes 10.5375% risk (volatility on return distribution) over the 90 days horizon. In different words, 93% of stocks are less volatile than OSTX, and 84% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
OS Therapies Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for OS Therapies' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as OS Therapies Incorporated, and traders can use it to determine the average amount a OS Therapies' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0799
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | OSTX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 10.54 actual daily | 93 93% of assets are less volatile |
Expected Return
| 0.84 actual daily | 16 84% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average OS Therapies is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of OS Therapies by adding it to a well-diversified portfolio.
OS Therapies Fundamentals Growth
OSTX Stock prices reflect investors' perceptions of the future prospects and financial health of OS Therapies, and OS Therapies fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on OSTX Stock performance.
| Current Valuation | 90.74 M | ||||
| Shares Outstanding | 20.88 M | ||||
| EBITDA | (3.18 M) | ||||
| Net Income | (7.79 M) | ||||
| Total Debt | 14.61 M | ||||
| Book Value Per Share | (4.52) X | ||||
| Cash Flow From Operations | (3.01 M) | ||||
| Earnings Per Share | (0.32) X | ||||
| Total Asset | 798.08 K | ||||
| Retained Earnings | (29.52 M) | ||||
About OS Therapies Performance
Evaluating OS Therapies' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if OS Therapies has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if OS Therapies has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
OS Therapies is entity of United States. It is traded as Stock on NYSE MKT exchange.Things to note about OS Therapies performance evaluation
Checking the ongoing alerts about OS Therapies for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for OS Therapies help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| OS Therapies is way too risky over 90 days horizon | |
| OS Therapies appears to be risky and price may revert if volatility continues | |
| OS Therapies has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (7.79 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| OS Therapies generates negative cash flow from operations | |
| OS Therapies has a frail financial position based on the latest SEC disclosures | |
| About 25.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing OS Therapies' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether OS Therapies' stock is overvalued or undervalued compared to its peers.
- Examining OS Therapies' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating OS Therapies' management team can have a significant impact on its success or failure. Reviewing the track record and experience of OS Therapies' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of OS Therapies' stock. These opinions can provide insight into OS Therapies' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for OSTX Stock Analysis
When running OS Therapies' price analysis, check to measure OS Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OS Therapies is operating at the current time. Most of OS Therapies' value examination focuses on studying past and present price action to predict the probability of OS Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OS Therapies' price. Additionally, you may evaluate how the addition of OS Therapies to your portfolios can decrease your overall portfolio volatility.